What is the main business of Silpharma?

The main business activity of Silpharma focuses on agents involved in the sale of specialised goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 17, 2021.

Where is the headquarters located?

The headquarters is located at: Aleja Jana Pawła Ii 27, 00-867 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

How much revenue was generated?

The company reported a revenue of $641 in 2022, which is a decrease of 47.2% compared to 2021.

Is the company profitable?

No, the company recorded a net loss of $1,909 in 2022. For comparison, in 2021 the loss was $2,291, meaning the company reduced its loss by 3.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $1,536 in 2022, representing 60% of all operating expenses.

Silpharmasp. z o.o.

Agents specialised in the sale of other particular products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-02-17

Share capital

5,000.00 PLN

Registered address

Aleja Jana Pawła II 27, 00-867 Warszawa, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 460 days for 2021).

2023not filed
202226/07/2024
202118/10/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue

This companyUSD 640.65MedianUSD 226.53kAverageUSD 2.28m

Net profit

This companyUSD -1.91kMedianUSD 6.25kAverageUSD 141.69k

Operating costs

This companyUSD 2.55kMedianUSD 187.76kAverageUSD 2.07m

Assets

This companyUSD 14.92kMedianUSD 163.28kAverageUSD 1.33m

Industry

Authorized Representatives

Robert Michał Balik – President of the Management Board

Sylwia Kalina Borysewicz – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Robert Michał Balikage 42	34	$459.21	34%
Sylwia Kalina Borysewiczage 54	33	$445.71	33%
Bartosz Jerzy Maźage 51	33	$445.71	33%

Beneficial owners

No beneficial owners recorded for the company Silpharma.

Bank accounts

Registered as a VAT taxpayer on 2021-02-27.

mBank
21 1140 2004 0000 3102 8096 8875

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
SynektikS.A.	$20,028,244.70	synektik.pl
Energy Centersp. z o.o.	$6,768,722.42	energy-center.pl
Sądkiewicz-Servicesp. k.	$3,829,148.99	sadkiewicz-service.eu
Symkomsp. z o.o.	$3,686,071.92	symkom.pl
Business Solutions & Supportsp. z o.o.	$2,174,692.02	motopatent.pl
East Newssp. z o.o.	$1,827,508.06	eastnews.pl
Cambridge Diagnostics (Polska)sp. z o.o.	$881,792.63	cambridge-diagnostics.pl
En-Brokersp. z o.o.	$184,094.49	en-broker.com
Koperkowy Światsp. z o.o.	$170,940.67	koperkowyswiat.pl
Aesthetica Groupsp. z o.o.	–	aestheticagroup.com

FAQ

Last updated: 2026-04-24